Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Aymeric Sallin resigned as Director at Cartesian Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On February 28, 2024, Aymeric Sallin, a member of the Board of Directors (the “Board”) of the Company, notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Cartesian Therapeutics, Inc. entered into Lease Agreement with 7495 RP, LLC valued at Initial base rent of $902,353 per year for approximately 20,000 leasable square feet (effective 2024-02-28).
- Action
- entry
- Agreement
- lease
- Counterparty
- 7495 RP, LLC
- Value
- Initial base rent of $902,353 per year for approximately 20,000 leasable square feet
- Effective
- 2024-02-28
Exact text from the filing
On February 28, 2024, Cartesian Therapeutics, Inc. (the “Company”) entered into a lease agreement with 7495 RP, LLC (the “Landlord”), pursuant to which the Company agreed to lease from the Landlord the manufacturing space located at 7495 New Horizon Way, Frederick, Maryland 21702 (the “Lease Agreement”).
View on SEC.gov